Table 3.
Baseline and post-45-day VLCKD dermatological parameters of women with acne and obesity
| Parameters (N = 31) | Baseline | Post 45 days of active phase of VLCKD | p-value | ∆% |
|---|---|---|---|---|
| GAGS | 24.26 ± 3.61 | 16.48 ± 2.46 | < 0.001 | − 31.46 ± 9.53 |
| Mild-severity (1–18) | – | 27 (87.1) | χ2 = 44.35, p < 0.001 | |
| Moderate-severity (19–30) | 31 (100.0) | 4 (12.9) | ||
| DLQI | 14.55 ± 4.46 | 7.32 ± 3.28 | < 0.001 | − 45.44 ± 24.02 |
| Small effect on QoL (2–5) | 1 (3.2) | 10 (32.3) | χ2 = 7.07, p = 0.008 | |
| Moderate effect on QoL (6–10) | 5 (16.1) | 16 (51.6) | χ2 = 7.20, p = 0.007 | |
| Very large effect on QoL (11–20) | 22 (71.0) | 5 (16.1) | χ2 = 16.80, p < 0.001 | |
| Extremely large effect on QoL (21–30) | 3 (9.7) | – | χ2 = 1.40, p = 0.237 |
VLCKD very low-calorie ketogenic diet, Δ% percentage change, GAGS global acne grading system, DLQI dermatology life quality index, QoL quality of life
A p-value in bold type denotes a significant difference (p < 0.05)